Physician

Julie V Levengood, MD

According to 2025 Medicare claims, Julie Levengood, MD (NPI: 1457335887) practices rheumatology in the Asheville, NC market, with the plurality of this provider's patient population coming from Buncombe, NC. This provider's primary affiliated billing organization is ASHEVILLE ARTHRITIS AND OSTEOPOROSIS CENTER, P.A. (NPI: 1780647578; TIN: 56-1426545) and primary practice location at 28803-1700. Levengood is affiliated with the Mission Health Partners, LLC (ACO ID: A2591) and Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Levengood's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 459 traditional Medicare patients, billed 172,420 HCPCS/CPT codes, and received $1,699,407 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,628 prescription claims across 336 beneficiaries totaling $2,312,513 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 21 records totaling $508. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $257,744 to $1,699,407. Similarly, Part D prescription costs have moved sharply higher in recent years, from $273,107 to $2,312,513. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$890K$1.8M2015 Medicare payment: $257,744 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $637,508 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $856,871 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,009,954 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,271,481 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,446,713 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,780,645 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,690,763 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,587,054 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,699,407 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201530610,412$257,744
201643533,251$637,508
201741945,081$856,871
201838748,617$1,009,954
201943568,417$1,271,481
202042889,169$1,446,713
2021525103,233$1,780,645
2022485116,315$1,690,763
2023500148,746$1,587,054
2024459172,420$1,699,407

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.2M$2.3M2015 Drug cost: $273,107 (USD; Tot_Drug_Cst)2016 Drug cost: $533,525 (USD; Tot_Drug_Cst)2017 Drug cost: $822,067 (USD; Tot_Drug_Cst)2018 Drug cost: $929,308 (USD; Tot_Drug_Cst)2019 Drug cost: $1,068,239 (USD; Tot_Drug_Cst)2020 Drug cost: $1,228,038 (USD; Tot_Drug_Cst)2021 Drug cost: $1,520,311 (USD; Tot_Drug_Cst)2022 Drug cost: $1,689,482 (USD; Tot_Drug_Cst)2023 Drug cost: $2,209,996 (USD; Tot_Drug_Cst)2024 Drug cost: $2,312,513 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151961,595$273,107
20162722,085$533,525
20172952,326$822,067
20182822,197$929,308
20192982,363$1,068,239
20203172,561$1,228,038
20213402,456$1,520,311
20223422,589$1,689,482
20233202,356$2,209,996
20243362,628$2,312,513

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more224370$86
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's248406$12
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count241545$7
86140Measurement c-reactive protein for detection of infection or inflammation244537$5
85652Red blood cell sedimentation rate, to detect inflammation, automated233511$3

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Humira(Cf) PenAdalimumab501,456$352,461
EnbrelEtanercept461,288$347,541
RinvoqUpadacitinib431,290$274,703
TremfyaGuselkumab12672$169,446
Orencia ClickjectAbatacept28784$161,261

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.21$508ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Julie V. Levengood, MD?

Tedicare shows public-source Medicare data for Julie V. Levengood, MD (NPI 1457335887), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Julie V. Levengood, MD have ACO affiliation data?

Julie V. Levengood, MD is shown with ACO affiliation data for Mission Health Partners, LLC (MSSP, ACO ID A2591) and Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Julie V. Levengood, MD?

Julie V. Levengood, MD is linked to ASHEVILLE ARTHRITIS AND OSTEOPOROSIS CENTER, P.A. (billing NPI 1780647578) in the available physician profile data.

Does Julie V. Levengood, MD have Open Payments data?

Julie V. Levengood, MD has 21 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.